Analysis of data for a subgroup of children with complex behavioral problems showed that Mel was successful as a first-use medication in 11/15 (73.4%) children, while DexL and DexN were successful in 100% (Figure 1B)
M.et al (2009)
The 15 of the 157 is because its a pentadeca peptide
By reducing inflammation in the gut, BPC-157 may help alleviate symptoms such as abdominal pain and bloating, leading to improved digestive comfort
Who Should Avoid It No safety studies on four-peptide combination Long-term effects completely unknown FDA has not approved any component for therapeutic use Stop Right Away If You Notice Severe injection site reactions or infection Allergic reactions (rash, difficulty breathing) Unusual fatigue or weakness Signs of copper toxicity (nausea, jaundice) Worsening of underlying conditions Milder Signs to Watch For How Long Should a Klow Blend (GHK-Cu, KPV, BPC-157, TB-500) Cycle Last
In people with T2D, a phase 1b study did not demonstrate improvement in HbA1c, however there was a placebo-adjusted WL of 8.5% after 12 weeks (Table 3)